Trends in inflammatory bowel disease therapy /
"This book contains the proceedings of the 66th International Falk Symposium to be sponsored jointly by the Canadian Association of Gastroenterology and Interfalk Canada Inc. focusing on inflammatory bowel disease therapy." "The meeting concentrated on issues of major concern to clini...
| Corporate Authors: | , , , , |
|---|---|
| Other Authors: | , , |
| Format: | Conference Proceeding Book |
| Language: | English |
| Published: |
Dordrecht ; Boston :
Kluwer Academic Publishers,
[1993], ©1993
Dordrecht ; Boston : c1993 |
| Series: | Falk symposium (Series) ;
66 |
| Subjects: |
| LEADER | 09279nam a2200829 a 4500 | ||
|---|---|---|---|
| 001 | 27d4c64a-699d-413d-a360-f22bf27b1d33 | ||
| 005 | 20240630000000.0 | ||
| 008 | 910226t19931993ne a b 101 0 eng c | ||
| 010 | |a 93234830 | ||
| 020 | |a 0792388275 | ||
| 035 | |9 AHK6044HS | ||
| 035 | |a (CStRLIN)NYCM91-B1411 | ||
| 035 | |a (NNC)3976621 | ||
| 035 | |a (NhCcYBP)YBP99088152849 | ||
| 035 | |a (NhCcYBP)YBT 93234830 | ||
| 035 | |a (OCoLC)28641378 |z (OCoLC)79601811 | ||
| 035 | |a (OCoLC)28641378 | ||
| 035 | |a (OCoLC)ocm28641378 | ||
| 035 | |a 3976621 | ||
| 040 | |a DLC |c DLC |d OrLoB-B |d OCoLC | ||
| 040 | |a DNLM/DLC |c DLC |d NNC-M | ||
| 040 | |a MDU |c MDU |d GZH |d HMS | ||
| 050 | 0 | 0 | |a RC862.I53 |b F35 1990 |
| 050 | 0 | 0 | |a RC862.I53 |b F35 1992 |
| 060 | 0 | |a WI 522 F191t 1990 | |
| 060 | 4 | |a WI 522 |b F191 1992t | |
| 082 | 0 | 0 | |a 616.3/44 |2 20 |
| 090 | |a RC862.I53 |b F35 1992 | ||
| 111 | 2 | |a Falk Symposium |n (66th : |d 1992 : |c Quebec City, Québec) | |
| 111 | 2 | |a Falk Symposium |n (66th : |d 1992 : |c Québec, Québec) | |
| 111 | 2 | |a Falk Symposium |n (66th : |d 1992 : |c Québec, Québec) | |
| 245 | 1 | 0 | |a Trends in inflammatory bowel disease therapy / |c edited by F. Martin ... [et al.] |
| 260 | |a Dordrecht ; |a Boston : |b Kluwer Academic Publishers, |c [1993], ©1993 | ||
| 260 | |a Dordrecht ; |a Boston : |b Kluwer Academic Publishers, |c c1993 | ||
| 300 | |a xiv, 364 p. : |b ill. ; |c 24 cm | ||
| 300 | |a xiv, 364 p. : |b ill. ; |c 25 cm | ||
| 300 | |a xiv, 364 pages : |b illustrations ; |c 24 cm | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a unmediated |b n |2 rdamedia | ||
| 338 | |a volume |b nc |2 rdacarrier | ||
| 490 | 1 | |a Falk symposium ; |v 66 | |
| 500 | |a "Proceedings of the 66th Falk Symposium held at Quebec City, Canada, May 20-23, 1992." | ||
| 500 | |a "Proceedings of the 66th Falk Symposium held in Quebec City, Canada, May 20-23, 1992." | ||
| 500 | |a "Sponsored jointly by the Canadian Association of Gastroenterology and Interfalk Canada Inc."--P. [ii] | ||
| 500 | |a "Sponsored jointly by the Canadian Association of Gastroenterology and Interfalk Canada Inc."--P. facing t.p | ||
| 504 | |a Includes bibliographical references and index | ||
| 505 | 0 | 0 | |g 1 |t Genetics and epidemiology may contribute to understanding the pathogenesis of IBD - a new approach is now indicated / |r A. S. Pena, J. B. A. Crusius, M. O. Pool, M. G. Casanova, G. Pals, S. G. M. Meuwissen and M. J. Giphart -- |g 2. |t Neuropeptides, intestinal immunological integrity and inflammatory bowel disease / |r C. A. Ottaway -- |g 3. |t T cell-mediated immunity and tissue damage in the gut / |r T. T. MacDonald -- |g 4. |t Mucosal complement deposition in inflammatory bowel disease / |r T. S. Halstensen and P. Brandtzaeg -- |g 5. |t Autoimmunity in inflammatory bowel disease / |r K. M. Das -- |g 6. |t IBD: Progress in pathogenesis / |r C. Fiocchi, S. A. Strong, G. A. West and J. S. Klein -- |g 7. |t The role of macrophages in the pathogenesis of inflammatory bowel disease / |r Y. R. Mahida -- |g 8. |t Immunosuppressive and immunomodulatory therapy for inflammatory bowel disease / |r C. N. Bernstein and F. Shanahan -- |g 9. |t Inflammatory mediators in inflammatory bowel disease: Clues for designer therapy / |r J. L. Wallace -- |g 10. |t Corticosteroid therapy for IBD: Old and new / |r G. R. Greenberg -- |g 11. |t Antimicrobial therapy of inflammatory bowel disease: Implications for pathogenesis and management / |r R. B. Sartor -- |g 12. |t Epidemiology in inflammatory bowel disease: Unanswered questions - European perspective / |r V. Binder -- |g 13. |t IBD epidemiology: Ongoing issues and new ideas. The Canadian perspective / |r A. B. R. Thomson -- |g 14. |t Community wide analysis of IBD in Rochester, New York, January 1973 to December 1989: Epidemiologic description with detailed clinical analysis / |r S. P. Stowe, J. M. Stormont, A. N. Shah, L. N. Chessin, H. L. Segal and W. Y. Chey -- |g 15. |t A quality of life index for inflammatory bowel disease / |r E. J. Irvine -- |g 16. |t Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease / |r I. Bjarnason, A. Macpherson, S. Somaslindaram and K. Teahon -- |g 17. |t Gut toxicity of 5-ASA? / |r D. J. Leddin and K. M. Peltekian -- |g 18. |t Prostaglandins in inflammatory bowel disease therapy / |r L. R. Empey and R. N. Fedorak -- |g 19. |t Treatment of distal ulcerative colitis with lidocaine / |r S. Bjorck, A. Dahlstrom and H. Ahlman -- |g 20. |t Leukotriene B[subscript 4] in inflammatory bowel disease / |r W. F. Stenson -- |g 21. |t Immunoglobulin therapy in inflammatory bowel disease / |r D. S. Levine -- |g 22. |t Special issues in nutritional therapy of inflammatory bowel disease / |r C. N. Williams -- |g 23. |t Enteral feeding with elemental and nonelemental diets in Crohn's disease / |r D. Rigaud -- |g 24. |t The rationale for FK 506 in inflammatory bowel disease / |r J. C. Reynolds, D. R. Trellis, K. Abu-Elmagd and J. Fung -- |g 25. |t Recurrence in Crohn's disease / |r A. J. Greenstein -- |g 26. |t Risk factors for relapse and recurrence of ulcerative colitis and Crohn's disease / |r P. Rutgeerts -- |g 27. |t Inflammatory bowel disease: The pathology of recurrence / |r J. K. Kelly -- |g 28. |t Immunological predictors of recurrence in patients with inflammatory bowel disease / |r J. P. Wright -- |g 29. |t Prediction of acute relapse of Crohn's disease: A study of host nonspecific immune reactivity / |r E. Rene -- |g 30. |t Prevention of relapse in ulcerative colitis using oral or topical 5-aminosalicylic acid therapy / |r L. R. Sutherland -- |g 31. |t Preventing relapse in Crohn's disease / |r J.-P. Gendre -- |g 32. |t Comparative trial of remission prophylaxis in quiescent Crohn's disease with oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets / |r S. Howaldt, A. Raedler, H.-C. Reinecker, D. Berghaus, S. Hoyer, B. Kaiser and S. Schreiber -- |g 33. |t Treatment of the steroid-resistant patient / |r R. A. Kozarek -- |g 34. |t Crohn's disease: The benefits of extensive surgery / |r B. G. Wolff -- |g 35. |t Crohn's disease: The benefits of minimal surgery / |r J. J. Tjandra and V. W. Fazio -- |g 36. |t Ileoanal pouches - Is mucosectomy essential? / |r R. R. Dozois and E. Juhasz -- |g 37. |t Ileoanal pouches - Is mucosectomy unnecessary? / |r Z. Cohen -- |g 38. |t Management of perianal Crohn's disease / |r M. R. B. Keighley -- |g 39. |t Perianal Crohn's disease - An active approach / |r G. Hellers. |
| 520 | 1 | |a "This book contains the proceedings of the 66th International Falk Symposium to be sponsored jointly by the Canadian Association of Gastroenterology and Interfalk Canada Inc. focusing on inflammatory bowel disease therapy." "The meeting concentrated on issues of major concern to clinicians, presenting new and important data in the following areas: genetic factors in IBD; other aspects of pathogenesis: clues for future therapy; life-style issues facing the (young) patient; diagnosis of IBD: What is new?; medical therapy of Crohn's disease and ulcerative colitis including pediatric therapy; diagnosis and management of extraintestinal manifestations; the emerging cancer risk in CD; surgical options in IBD; recurrence of CD and UC; and recurrence of CD after surgery."--Jacket | |
| 561 | 1 | |a From the Boston Medical Library |8 221902288800003941 | |
| 650 | 0 | |a Inflammatory bowel diseases |x Treatment |v Congresses | |
| 650 | 2 | |a Inflammatory Bowel Diseases |x physiopathology |v Congresses | |
| 650 | 2 | |a Inflammatory Bowel Diseases |x physiopathology | |
| 650 | 2 | |a Inflammatory Bowel Diseases |x therapy |v congresses | |
| 650 | 2 | |a Inflammatory Bowel Diseases |x therapy | |
| 650 | 7 | |a Inflammatory bowel diseases |x Treatment |2 fast | |
| 655 | 2 | |a Congress | |
| 655 | 7 | |a Conference papers and proceedings |2 fast |0 http://id.worldcat.org/fast/1423772 | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 700 | 1 | |a Martin, F |0 http://viaf.org/viaf/304981392 | |
| 700 | 1 | |a Martin, F |q (François) |1 http://viaf.org/viaf/89293264 | |
| 700 | 1 | |a Martin, F |q (François) |0 http://viaf.org/viaf/89293264 | |
| 710 | 2 | |a Canadian Association of Gastroenterology |0 http://viaf.org/viaf/167518070 | |
| 710 | 2 | |a Canadian Association of Gastroenterology |1 http://viaf.org/viaf/167518070 | |
| 710 | 2 | |a Interfalk Canada Inc |0 http://viaf.org/viaf/150035355 | |
| 710 | 2 | |a Interfalk Canada Inc |1 http://viaf.org/viaf/150035355 | |
| 830 | 0 | |a Falk symposium (Series) ; |v 66 | |
| 999 | 1 | 0 | |i 27d4c64a-699d-413d-a360-f22bf27b1d33 |l 3672746 |s US-ICU |m trends_in_inflammatory_bowel_disease_therapy_______________________________1993_______kluwea________________________________________falk_symposium_____________________p |
| 999 | 1 | 0 | |i 27d4c64a-699d-413d-a360-f22bf27b1d33 |l 990038181580203941 |s US-MH |m trends_in_inflammatory_bowel_disease_therapy_______________________________1993_______kluwea________________________________________falk_symposium_____________________p |
| 999 | 1 | 0 | |i 27d4c64a-699d-413d-a360-f22bf27b1d33 |l 3976621 |s US-NNC |m trends_in_inflammatory_bowel_disease_therapy_______________________________1993_______kluwea________________________________________falk_symposium_____________________p |
| 999 | 1 | 1 | |l 3672746 |s ISIL:US-ICU |t BKS |a ASR-SciASR |b 50640465 |c RC862.I53 F35 1992 |d Library of Congress classification |y 6095596 |p LOANABLE |
| 999 | 1 | 1 | |l 990038181580203941 |s ISIL:US-MH |t BKS |a MED BML-HD |b 32044118278118 |c WI 522 F191 1992t |d 2 |x 89 BOOK |y 231902288770003941 |p UNLOANABLE |
| 999 | 1 | 1 | |l 3976621 |s ISIL:US-NNC |t BKS |a off,hsl |b HS64806685 |c RC862.I53 F35 1992 |y 4067921 |p LOANABLE |